Cargando…
A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838897/ https://www.ncbi.nlm.nih.gov/pubmed/33396226 http://dx.doi.org/10.3390/pharmacy9010006 |
_version_ | 1783643285883977728 |
---|---|
author | Takeda, Kayoko Arakawa, Naoko |
author_facet | Takeda, Kayoko Arakawa, Naoko |
author_sort | Takeda, Kayoko |
collection | PubMed |
description | Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was implemented in 2006. In this study, we provide the comparative results of the first cycle of the third-party accrediting organization, the Japan Accreditation Board for Pharmaceutical Education (JABPE); Methods: The results of the first cycle of all universities or schools of pharmacy assessed by the JABPE from JABPE website were retrieved, and we collated and compared the results based on the 13 areas of the assessment standards; Results: In “improvements”, the number of public universities or schools was less than that of private universities or schools, and the number of old private universities or schools was also less than the number of new private universities or schools in all assessment areas. Conclusions: These results suggest that new universities or schools established since 2003 have not yet established their own quality assurance mechanism within the institutions. We need to review the Japanese pharmacy education system or the assessment criteria for it to bring about essential change. |
format | Online Article Text |
id | pubmed-7838897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78388972021-01-28 A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan Takeda, Kayoko Arakawa, Naoko Pharmacy (Basel) Case Report Background: The Standards for the Establishment of Universities in Japan were revised; subsequently, the number of schools or universities of pharmacy/pharmaceutical sciences increased from 46 in 2002 to 74 in 2016.The pharmacy education programme was also changed from four to six years, which was implemented in 2006. In this study, we provide the comparative results of the first cycle of the third-party accrediting organization, the Japan Accreditation Board for Pharmaceutical Education (JABPE); Methods: The results of the first cycle of all universities or schools of pharmacy assessed by the JABPE from JABPE website were retrieved, and we collated and compared the results based on the 13 areas of the assessment standards; Results: In “improvements”, the number of public universities or schools was less than that of private universities or schools, and the number of old private universities or schools was also less than the number of new private universities or schools in all assessment areas. Conclusions: These results suggest that new universities or schools established since 2003 have not yet established their own quality assurance mechanism within the institutions. We need to review the Japanese pharmacy education system or the assessment criteria for it to bring about essential change. MDPI 2020-12-31 /pmc/articles/PMC7838897/ /pubmed/33396226 http://dx.doi.org/10.3390/pharmacy9010006 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Takeda, Kayoko Arakawa, Naoko A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title | A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title_full | A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title_fullStr | A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title_full_unstemmed | A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title_short | A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan |
title_sort | comparative exploration of quality assurance results by the third-party pharmaceutical education evaluation in japan |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838897/ https://www.ncbi.nlm.nih.gov/pubmed/33396226 http://dx.doi.org/10.3390/pharmacy9010006 |
work_keys_str_mv | AT takedakayoko acomparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan AT arakawanaoko acomparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan AT takedakayoko comparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan AT arakawanaoko comparativeexplorationofqualityassuranceresultsbythethirdpartypharmaceuticaleducationevaluationinjapan |